Reducing the Acute Care Burden of Childhood Asthma on Health Services in British Columbia
This trial is active, not recruiting.
|Conditions||upper respiratory tract infection, asthma|
|Treatment||arm 1 oral cortico steroids|
|Sponsor||University of British Columbia|
|Start date||April 2011|
|End date||May 2012|
|Trial size||92 participants|
|Trial identifier||NCT01326494, H10-00184|
The purpose of this study is to investigate the benefits of giving filled prescription of a medication to be used upon early onset of symptoms of URTI induced asthma. The hope is to reduce the need to present to Health Care centres for treatment.
|Endpoint classification||safety/efficacy study|
|Intervention model||parallel assignment|
Reduction of representation to Health Services for Exacerbation of URTI induced asthma
time frame: One year
Male or female participants from 12 months up to 18 years old.
Inclusion Criteria: - 2 or more presentations to Emergency department in a 12 month period Exclusion Criteria: - less then 2 presentations to Emergency department in a 12 month period
|Official title||Reducing the Acute Care Burden of Childhood Asthma on Health Services in British Columbia|
|Principal investigator||Bruce Carleton, B.Pharm, Pharm.D.|
|Description||In Canada, asthma affects more the 12% of children. Exacerbation are a common feature of asthma. In children, upper respiratory tract infection (URTI's) are responsible for over 80% of asthma exacerbation. Experts in asthma care acknowledge this critical problem and have developed guidelines to reduce asthma exacerbation. The criteria for participation in this study to have 2 or more presentations to a Health Service centre in the past 12 months for URTI induced asthma. These patients will be followed and interviewed monthly over a 12 month period to investigate whether the use of Oral cortico-steroids upon early onset of URTI induced asthma prevents the need for presentation to hospital|
Call for more information